author-photo

Jennifer L. McNeer

University of Chicago

49

Papers

586

Citations

Citation Trend

Filter By

Papers (33) Sort By

Journal Conference Others

Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-risk Leukemias: A Report from the LEAP Consortium

2021 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (5)
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children’s Oncology Group Protocol AALL1732

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Updates in Childhood Leukemia

2021
- Jennifer L. McNeer
Show All
- Source
- Cite
- Save
Citations (0)
Integration and feasibility of symptom burden assessment and early palliative care into an adolescent and young adult leukemia clinic.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment.

2020 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Cutting to the Front of the Line: Immunotherapy for Childhood Acute Lymphoblastic Leukemia

2020
Show All
- Source
- Cite
- Save
Citations (7)
Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study

2020 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (34)
Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (25)
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP Consortium

2018 Blood
Show All
- Source
- Cite
- Save
Citations (2)